<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Open Congress : News Articles for H.R.3580 Food and Drug Administration Amendments Act of 2007</title>
  <link href="http://www.opencongress.org/bill/110-h3580/atom_news" rel="self"/>
  <link href="http://www.opencongress.org/bill/110-h3580/news" rel="alternate"/>
  <updated>2007-09-30T20:00:00Z</updated>
  <author>
    <name>opencongress.org</name>
  </author>
  <id>tag:opencongress.org,2007:/bill/news/46215</id>
  <entry>
    <title>Bush Signs FDA Legislation</title>
    <link href="http://www.aafp.org/online/en/home/publications/news/news-now/government-medicine/20071001fdaoversight.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-30:/commentary/1190732</id>
    <updated>2007-09-30T20:00:00Z</updated>
    <author>
      <name>AAFP News Now</name>
    </author>
    <content type="html">
The Food and Drug Administration Amendments Act of 2007, HR 3580, (at the Library of Congress' THOMAS Web site type &quot;HR 3580&quot; in the search bar after ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.aafp.org/online/en/home/publications/news/news-now/government-medicine/20071001fdaoversight.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>American Academy of Dermatology Association Commends President ...</title>
    <link href="http://usstock.jrj.com.cn/news/2007-09-29/000002741522.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-27:/commentary/1249506</id>
    <updated>2007-09-27T20:00:00Z</updated>
    <author>
      <name>&amp;#37329;&amp;#34701;&amp;#30028;,&amp;nbsp;China</name>
    </author>
    <content type="html">
As part of the more comprehensive &quot;Food and Drug Administration Amendments Act of 2007 (HR 3580),&quot; the TAN Act directs the US Food and Drug Administration ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://usstock.jrj.com.cn/news/2007-09-29/000002741522.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>President Bush Signs Into Law Legislation To Reauthorize ...</title>
    <link href="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=47844" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-27:/commentary/1171075</id>
    <updated>2007-09-27T20:00:00Z</updated>
    <author>
      <name>Kaiser network.org,&amp;nbsp;DC</name>
    </author>
    <content type="html">
President Bush on Tuesday signed into law a bill (HR 3580) that will expand FDA oversight of prescription drug safety and reauthorize the Prescription Drug ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=47844&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>FDA Act Brings Big Changes</title>
    <link href="http://www.patentbaristas.com/archives/2007/09/28/fda-act-brings-big-changes/" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-27:/commentary/1171074</id>
    <updated>2007-09-27T20:00:00Z</updated>
    <author>
      <name>Patent Baristas,&amp;nbsp;OH</name>
    </author>
    <content type="html">
The Senate passed the bill, HR 3580, by unanimous consent on Sept. 20, a day after the House approved it in a 409-17 vote. The massive 422-page FDA bill, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.patentbaristas.com/archives/2007/09/28/fda-act-brings-big-changes/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>American Academy of Dermatology Association Commends President ...</title>
    <link href="http://www.earthtimes.org/articles/show/news_press_release,188005.shtml" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-27:/commentary/1170946</id>
    <updated>2007-09-27T20:00:00Z</updated>
    <author>
      <name>Earthtimes.org</name>
    </author>
    <content type="html">
As part of the more comprehensive &quot;Food and Drug Administration Amendments Act of 2007 (HR 3580),&quot; the TAN Act directs the US Food and Drug Administration ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.earthtimes.org/articles/show/news_press_release,188005.shtml&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Congress Passes Compromise FDA Bill Reauthorizing PDUFA</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10777&amp;amp;amp;articleId=98981" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-25:/commentary/1252504</id>
    <updated>2007-09-25T20:00:00Z</updated>
    <author>
      <name>FDA news (subscription),&amp;nbsp;VA</name>
    </author>
    <content type="html">
The Senate passed the bill, HR 3580, Sept. 20 without amendment through unanimous consent procedure, which does not require a roll call vote. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10777&amp;amp;amp;articleId=98981&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>The Food &amp;amp; Drug Letter</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10774&amp;amp;amp;articleId=98957" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-25:/commentary/1190733</id>
    <updated>2007-09-25T20:00:00Z</updated>
    <author>
      <name>FDA news (subscription),&amp;nbsp;VA</name>
    </author>
    <content type="html">
The House and Senate recently passed the FDA Amendment Act (FDAAA), HR 3580, which would reauthorize the Prescription Drug User Fee Act (PDUFA) and give the ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10774&amp;amp;amp;articleId=98957&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>HDMA Commends Congressional Enactment Of Food And Drug ...</title>
    <link href="http://www.medicalnewstoday.com/articles/83608.php" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-25:/commentary/1166179</id>
    <updated>2007-09-25T20:00:00Z</updated>
    <author>
      <name>Medical News Today (press release),&amp;nbsp;UK</name>
    </author>
    <content type="html">
HDMA commends the US House of Representatives and the Senate for passing the Food and Drug Administration Amendments Act (HR 3580), which includes important ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.medicalnewstoday.com/articles/83608.php&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>HR 3580 to Decrease Number of Conflict-of-Interest Waivers</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10774&amp;amp;amp;articleId=98960" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-25:/commentary/1166178</id>
    <updated>2007-09-25T20:00:00Z</updated>
    <author>
      <name>FDA news (subscription)</name>
    </author>
    <content type="html">
The issue of conflict-of-interest waivers in the Prescription Drug User Fee Act (PDUFA) reauthorization legislation highlighted the balance between keeping ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10774&amp;amp;amp;articleId=98960&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>ACI: Drug and Medical Device Litigation Conference -- Agenda ...</title>
    <link href="http://www.marketwire.com/mw/release.do?id=773531" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-24:/commentary/1249505</id>
    <updated>2007-09-24T20:00:00Z</updated>
    <author>
      <name>Market Wire (press release)</name>
    </author>
    <content type="html">
The Senate and House drug safety proposals have been reconciled and the bill (HR 3580) will go to the President. Language that would have enabled ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.marketwire.com/mw/release.do?id=773531&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>ACI: Drug and Medical Device Litigation Conference -- Agenda ...</title>
    <link href="http://www.sys-con.com/read/434453.htm" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-24:/commentary/1161913</id>
    <updated>2007-09-24T20:00:00Z</updated>
    <author>
      <name>Web Services Journal,&amp;nbsp;NJ</name>
    </author>
    <content type="html">
The Senate and House drug safety proposals have been reconciled and the bill (HR 3580) will go to the President. Language that would have enabled ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.sys-con.com/read/434453.htm&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Approves Legislation That Would Reauthorize Prescription ...</title>
    <link href="http://www.medicalnewstoday.com/articles/83350.php" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-24:/commentary/1155560</id>
    <updated>2007-09-24T20:00:00Z</updated>
    <author>
      <name>Seattle Times</name>
    </author>
    <content type="html">
The Senate on Thursday by voice vote approved a compromise bill (HR 3580) that would expand FDA oversight of prescription drug safety and reauthorize the ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.medicalnewstoday.com/articles/83350.php&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Congress Passes Compromise FDA Bill Reauthorizing MDUFMA</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10765&amp;amp;amp;articleId=98876" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-23:/commentary/1155559</id>
    <updated>2007-09-23T20:00:00Z</updated>
    <author>
      <name>FDA news (subscription),&amp;nbsp;VA</name>
    </author>
    <content type="html">
The Senate passed the bill, HR 3580, Sept. 20 without amendment through unanimous consent procedure, which does not require a roll call vote. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10765&amp;amp;amp;articleId=98876&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Area Votes in Congress</title>
    <link href="http://www.philly.com/philly/news/20070923_Area_Votes_in_Congress.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-22:/commentary/1149086</id>
    <updated>2007-09-22T20:00:00Z</updated>
    <author>
      <name>Philadelphia Inquirer,&amp;nbsp;PA</name>
    </author>
    <content type="html">
A yes vote was to pass the bill (HR 3580). Voting yes: Brady, Castle, Dent, Fattah, Gerlach, Holden, LoBiondo, Murphy, Pitts, Saxton, Schwartz, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.philly.com/philly/news/20070923_Area_Votes_in_Congress.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Thomas Voting Reports</title>
    <link href="http://www.thenewstribune.com/news/government/story/162604.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-22:/commentary/1149085</id>
    <updated>2007-09-22T20:00:00Z</updated>
    <author>
      <name>TheNewsTribune.com (subscription),&amp;nbsp;WA</name>
    </author>
    <content type="html">
A yes vote backed a bill (HR 3580) enabling the FDA for the first time to monitor drugs long after they are marketed. Voting yes: Inslee, Larsen, Baird, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.thenewstribune.com/news/government/story/162604.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>How your US lawmaker voted</title>
    <link href="http://seattletimes.nwsource.com/html/localnews/2003897804_rollcall23.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-22:/commentary/1149084</id>
    <updated>2007-09-22T20:00:00Z</updated>
    <author>
      <name>Seattle Times,&amp;nbsp;United States</name>
    </author>
    <content type="html">
The bill (HR 3580) empowers the FDA for the first time to continually review drugs after they go on the market and order quick corrective action when ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://seattletimes.nwsource.com/html/localnews/2003897804_rollcall23.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Passes FDA Bill After Senators Remove Holds</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10762&amp;amp;amp;articleId=98846" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-20:/commentary/1142859</id>
    <updated>2007-09-20T20:00:00Z</updated>
    <author>
      <name>FDA news (subscription)</name>
    </author>
    <content type="html">
The House passed HR 3580, the FDA Amendments Act, by a vote of 405-17 a day earlier. It is a compromise containing provisions from both HR 2900 and S. 1082, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10762&amp;amp;amp;articleId=98846&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>House Approves Prescription Drug User Fee Act Reauthorization</title>
    <link href="http://www.emaxhealth.com/94/16232.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-19:/commentary/1136881</id>
    <updated>2007-09-19T20:00:00Z</updated>
    <author>
      <name>eMaxHealth.com,&amp;nbsp;NC</name>
    </author>
    <content type="html">
The House on Wednesday voted 405-7 to approve a compromise bill (HR 3580) that would expand FDA oversight of prescription drug safety and reauthorize the ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.emaxhealth.com/94/16232.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>GOP Hold Dropped, Clearing Way for Final Passage of FDA Bill</title>
    <link href="http://public.cq.com/docs/cqm/cqmidday110-000002589008.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-19:/commentary/1136880</id>
    <updated>2007-09-19T20:00:00Z</updated>
    <author>
      <name>Congressional Quarterly,&amp;nbsp;DC</name>
    </author>
    <content type="html">
Richard M. Burr of North Carolina had objected to provisions in the bill ( HR 3580 ) that he contended would allow for expanded lawsuits against drugmakers. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://public.cq.com/docs/cqm/cqmidday110-000002589008.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Pelosi: 'Today's Sweeping, Bipartisan Legislation to Improve Drug ...</title>
    <link href="http://digital50.com/news/items/PR/2007/09/19/DC03266/pelosi-todays-sweeping-bipartisan-legislation-to-improve-drug-safety-is-a-victory.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-18:/commentary/1252505</id>
    <updated>2007-09-18T20:00:00Z</updated>
    <author>
      <name>American Digital Networks (press release),&amp;nbsp;MD</name>
    </author>
    <content type="html">
19 prnewswire-usnewswire &amp;#8212; Speaker Nancy Pelosi issued the following statement today on HR 3580, FDA Amendments/Improving Drug Safety Act, which passed by a ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://digital50.com/news/items/PR/2007/09/19/DC03266/pelosi-todays-sweeping-bipartisan-legislation-to-improve-drug-safety-is-a-victory.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Pelosi: 'Today's Sweeping, Bipartisan Legislation to Improve Drug ...</title>
    <link href="http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&amp;amp;amp;STORY=/www/story/09-19-2007/0004666396&amp;amp;amp;EDATE=" rel="alternate"/>
    <id>tag:opencongress.org,2007-09-18:/commentary/1136946</id>
    <updated>2007-09-18T20:00:00Z</updated>
    <author>
      <name>Congressional Quarterly</name>
    </author>
    <content type="html">
19 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi issued the following statement today on HR 3580, FDA Amendments/Improving Drug Safety Act, which passed ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&amp;amp;amp;STORY=/www/story/09-19-2007/0004666396&amp;amp;amp;EDATE=&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
</feed>

